ArticleSmall methods2026
Centrifugal Step-Emulsification Platform for High-Throughput Emulsion Screening.
Article in Small methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A centrifugal emulsification platform enabling the parallel generation of emulsions directly in standard 96-well plates is introduced. Upon centrifugation, the dispersed phase is driven through capillaries into the continuous phase, where step emulsification yields droplets by clean pinch-off. The system achieves high reproducibility, with success rates above 90%. The platform's utility is demonstrated by screening silicone-oil/water emulsions across siloxane surfactants and NaCl gradients, and by mapping fluorinated emulsion stability as a function of salinity and the mixing ratio of two fluorinated surfactants of different chain lengths. In contrast to lab-on-a-disc systems or single-tube centrifugal devices, this approach combines minimal hardware requirements with high throughput and seamless compatibility with automated liquid-handling and imaging workflows. Its simplicity and scalability make it suited for closed-loop optimization, accelerating the discovery of sustainable non-fluorinated droplet systems and enabling systematic studies of emulsion stability across diverse formulation spaces.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.